Nitric oxide…Neurotransmitter?. B.Sc 2002. EDRF: endothelium-derived relaxing factor Furchgott in 1980 showed that Acetylcholine-stimulated relaxation of arterial smooth muscle required intact endothelium in the arteries.
Furchgott in 1980 showed that Acetylcholine-stimulated relaxation of arterial smooth muscle required intact endothelium in the arteries
Palmer & Moncada in late 1980’s showed that EDRF was nitric oxide, NO, synthesised by a specific enzyme, Nitric Oxide Synthase (NOS) NOS uses arginine and oxygen to produce NO and citrulline
Different forms of NOS exist. Constitutive forms and inducible forms. Neuronal NOS is constitutive, macrophage NOS is induced.
NADPH, and tetahydrobiopterin
The intermediate N-hydroxyarginine could be a storage form of NO. Superoxide anion may be an intermediate in NO synthesis
Brain NOS is present in CNS including specific neurons in cerebellum, hippocampus and olfactory lobes; and in NANC (non-adrenergic, non-cholinergic) nerves including innervation to gastrointestinal tract, pelvic organs and trachea.
Vascular NOS is present in platelets and renal mesangial cells in addition to endothelium.
NO was initially thought to is unstable but is stable at the partial pressures of oxygen found in the body. It is metabolised to nitrite and nitrate which are excreted in urine and provide an index of NO biosynthesis in humans receiving a low-nitrate diet.
How does NO work? cerebellum, hippocampus and olfactory lobes; and in NANC (non-adrenergic, non-cholinergic) nerves including innervation to gastrointestinal tract, pelvic organs and trachea.
Diffuses to cells other than the one where it was synthesised
Binds with soluble guanylate cyclase to form cGMP
cGMP acts to sequester intracellular calcium and close calcium channels
Drop in intracellular calcium causes relaxation
How is NO inactivated?
NO is oxidised to nitrite and then nitrate
Nitrate excreted in urine
What is physiological role of NO? cerebellum, hippocampus and olfactory lobes; and in NANC (non-adrenergic, non-cholinergic) nerves including innervation to gastrointestinal tract, pelvic organs and trachea.
NO appears to act to prevent hypoxia by causing vasodilation.
It forms a good mechanism to counter hypoxia BUT
It needs molecular oxygen to be synthesised
NO is a gas and cannot be stored in the tissue
Could there be a storage form?
Concept that NO is produced during periods of normoxia, stored as nitrosothiol or nitrite, converted back to NO in hypoxic conditions
Maybe hydroxy-arginine is a storage form
A sensible model of NO in the body would exist if NO could be stored in some way and form reversible complexes with haemoglobin
Then during hypoxia
NO would be released from storage to cause local vasodilation and unloading of oxygen from haemoglobin, forming nitroso-Hb
Nitroso-Hb is carried back to lungs and is converted back to oxyhaemoglobin. The released NO relaxes the lungs and increased oxygenation of Hb
Is nitrite the storage form? There MUST be some way to back-convert nitrite to NO as organic vasodilators (GTN, amyl nitrite) are effective!
Cerebral NO hypothesis: be stored in some way and form reversible complexes with haemoglobin
NOS controls CBF.
During normoxia NO is synthesised and blockade of this synthesis reduces CBF and ability to autoregulate
Freshly made NO is used to maintain calibre of cerebral capillaries
During hypoxia NO is released from storage forms; thus blockade of NOS does not affect NO response to hypoxia
Hypothesis 2: Role of NO in supporting neuronal activity be stored in some way and form reversible complexes with haemoglobin
NO acts to increase local blood flow to neurones during increased activity.
NO therefore matches perfusion to oxygen demand.
NO-containing neurones are stimulated by NMDA receptors. This allows calcium entry, Ca/calmodulin activates NOS and produces NO which diffuses to local blood vessels and causes dilation.Co-stored with GABA as GABA acts to reduce excess activity
The main features of generally accepted criteria for a neurotransmitter are as follows:
(1) A system for synthesis of the putative transmitter must be present.
(2) There must be a store of the putative transmitter in the axon terminals.
(3) The putative transmitter must be released by nerve stimulation.
(4) Administration of the putative transmitter must produce a response that mimics that produced by nerve stimulation.
(5) Drugs that modify the responses to the putative transmitter should have corresponding effects on the responses to nerve stimulation.
Is NO a ‘retrograde transmitter” neurotransmitter are as follows:
Blockade of NOS blocks LTP in hippocampal slices
NO may be made in post-synaptic neurone and diffuse back to presynaptic neurone. Suggested as a mechanism of synaptic strengthening.Problem with this idea is that not all neurones contain NOS.
NO & Pain neurotransmitter are as follows:
There are conflicting reports on the role of NO in the transmission of pain in the spinal cord.
NOS inhibitors have been reported to reduce responses to pain, but sometimes increase responses.
There is very good evidence for increased NO synthesis in the spinal cord in animals with chronic pain.
This increase may reflect more ongoing activity of neurones in chronic pain states rather than an increase in NO as a ‘pain transmitter”